Slide 1
COVID-19 Update

Lenti-Covid: robust answer addressing long-term immunity
against emerging variants

TheraVectys-AboutUs-OK
Breakthrough technology in vaccines
and immunotherapy

Transform global healthcare through novel lentiviral vector technology

Prophylactic and therapeutic vaccination

There is a globally unmet and critical need to prevent and treat infectious disease and cancer.
We support patients and healthcare providers by developing prophylactic and therapeutic
immunotherapies across a diverse pipeline, covering:

Thanks to our highly effective proprietary technology platform,
we have several investigational therapies already progressing through clinical trials.

NEWS